Targeting NAMPT as a therapeutic strategy against stroke

Stroke is the second and the leading most common cause of death in the world and China, respectively, but with few effective therapies. Nicotinamide phosphoribosyltransferase (NAMPT) is the rate-limiting enzyme for nicotinamide adenine dinucleotide (NAD) salvage synthesis in mammals, thereby influen...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shu-Na, Miao, Chao-Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613878/
https://www.ncbi.nlm.nih.gov/pubmed/31338216
http://dx.doi.org/10.1136/svn-2018-000199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6613878/
https://www.ncbi.nlm.nih.gov/pubmed/31338216
http://dx.doi.org/10.1136/svn-2018-000199

Ejemplares similares